SARS-CoV-2 Spike Protein IgM ELISA Kit

This Assay Genie indirect immunoassay targets the IgM isotype response against the SARS-CoV-2 spike glycoprotein, providing researchers with a tool to study early humoral immunity following natural infection or vaccination. The microplate is pre-coated with recombinant spike antigen to capture circulating IgM, which is then detected using an enzyme-conjugated secondary antibody system that produces a measurable enzymatic signal.

The kit supports investigation of seroconversion kinetics, mucosal and systemic antibody profiling, and evaluation of vaccine-induced immune responses in clinical research cohorts. It is suited to retrospective serum bank screening, longitudinal follow-up studies, and comparative analyses across variant strains. Each kit contains pre-titrated reagents, coated wells, buffers, standards, and conjugate prepared for direct use following equilibration to ambient conditions. Store refrigerated; avoid repeated freeze-thaw cycles of reconstituted materials to preserve antibody binding activity. For research use only.